Compare Danaher Corporation (DHR) vs Mercadolibre Inc (MELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Mercadolibre Inc — how do they compare? Danaher Corporation trades at $198.81 (market cap $140.88B), while Mercadolibre Inc trades at $1,877.96 (market cap $95.00B). The key difference: Danaher Corporation is the larger of the two by market cap, and Danaher Corporation pays a 0.8% dividend while Mercadolibre Inc pays none. Which is the better fit depends on your goals.
| DHR | MELI | |
|---|---|---|
Market Cap | $140.88B | $95.00B |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $2.51K |
52-Week Low | $161.91 | $1.55K |
Enterprise Value | $153.66B | $101.89B |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
MercadoLibre (MELI) trades at $1,867.30, up 0.81% today, with a bullish technical signal and strong analyst support. Recent financials show robust revenue growth to $28.89 billion in 2025, though net income margins compressed to 6.04%. The stock faces near-term pressure from three consecutive quarterly EPS misses but benefits from expanding cash flow and a dominant position in Latin American e-commerce and fintech.
Outlook remains positive with a consensus price target of $2,230, implying 19% upside, but risks include margin volatility from heavy investments and competitive threats. Institutional sentiment is strong with 72% buy ratings, though high P/E of 49.28 demands sustained growth to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →
